Oncology Nursing News®

Register now to learn about a new option for relapsed or refractory follicular lymphoma

Blood Cancers

FDA Approves Crizotinib for Pediatric/Young Adult ALK+ Anaplastic Large Cell Lymphoma

FDA Approves Crizotinib for Pediatric/Young Adult ALK+ Anaplastic Large Cell Lymphoma

BY KRISTI ROSA

Cavrotolimod Granted Fast Track Status for Merkel Cell Carcinoma, CSCC

Cavrotolimod Granted Fast Track Status for Merkel Cell Carcinoma, CSCC

BY KRISTI ROSA

$BET Inhibitor Shows Promise in Advanced Solid Tumors, Relapsed/Refractory NHL$

BET Inhibitor Shows Promise in Advanced Solid Tumors, Relapsed/Refractory NHL

BY HAYLEY VIRGIL

Early Study Lays Groundwork for Boosting Immunotherapy Response

Early Study Lays Groundwork for Boosting Immunotherapy Response

BY BRIELLE BENYON

Mental Health Screening Is Needed in Blood Cancer Space

Mental Health Screening Is Needed in Blood Cancer Space

BY RYAN MCDONALD

Ponatinib Approved by FDA for Resistant or Intolerant Chronic-Phase CML

Ponatinib Approved by FDA for Resistant or Intolerant Chronic-Phase CML

BY KRISTI ROSA

FDA Approves Selinexor Combination for Pretreated Patients with Myeloma

FDA Approves Selinexor Combination for Pretreated Patients with Myeloma

BY BRIELLE BENYON

FDA Approves Rituximab Biosimilar for Treatment of NHL, CLL, GPA, and MPA

FDA Approves Rituximab Biosimilar for Treatment of NHL, CLL, GPA, and MPA

BY KRISTI ROSA

Devimistat Granted Fast Track Designation for AML Treatment

Devimistat Granted Fast Track Designation for AML Treatment

BY KRISTI ROSA

Improving Outcomes for Patients Experiencing Financial Toxicity

Improving Outcomes for Patients Experiencing Financial Toxicity

BY COLLEEN MORETTI

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.